8. I. E. León, V. Porro, S. Astrada, M. G. Egusquiza, C. I. Cabello, M. Bollati-Fogolin and S. B. Etcheverry, Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model, Chem. Biol. Interact. 222 (2014) 87–96; https://doi.org/10.1016/j.cbi.2014.10.01210.1016/j.cbi.2014.10.01225451568
9. J. Zhao, S. Gou and F. Liu, Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand, Chemistry20 (2014) 15216–15225; https://doi.org/10.1002/chem.20140409010.1002/chem.20140409025256173
10. S. Iglesias, N. Alvarez, M. H. Torre, E. Kremer, J. Ellena, R. R. Ribeiro, R. P. Barroso, A. J. Costafilho, M. G. Kramer and G. Facchin, Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper complexes for the treatment of cancer, J. Inorg. Biochem. 139 (2014) 117–123; https://doi.org/10.1016/j.jinorgbio.2014.06.00710.1016/j.jinorgbio.2014.06.00725033418
12. V. M. Leovac, G. A. Bogdanović, L. S. Jovanović, L. Joksović, V. Marković, M. D. Joksović, S. M. Denčić, A. Isaković, I. Marković and F. W. Heinemann, Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl--3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde, J. Inorg. Biochem.105 (2011) 1413–1421; https://doi.org/10.1016/j.jinorgbio.2011.07.02110.1016/j.jinorgbio.2011.07.02121955843
13. X. Q. Zhou, Y. Li, D. Y. Zhang, Y. Nie, Z. J. Li, W. Gu, X. Liu, J. L. Tian and S. P. Yan, Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis, Eur. J. Med. Chem. 114 (2016) 244–256; https://doi.org/10.1016/j.ejmech.2016.02.05510.1016/j.ejmech.2016.02.05526994692
14. X. H. Wang, D. Z. Jia, Y. J. Liang, S. L. Yan, Y. Ding, L. M. Chen, Z. Shi, M. S. Zeng, G. F. Liu and L. W. Fu, Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway, Cancer. Lett. 249 (2007) 256–270; https://doi.org/10.1016/j.canlet.2006.09.00810.1016/j.canlet.2006.09.00817055640
15. C. Kou, J. Zhao, Y. Li, G. Xu and S. Sun, Acute toxicity test of different doses of copper complex of pyrazolone derivatives in mice, Chin. Hosp. Pharm. J. 36 (2016) 821–825 (In Chinese).
16. G. C. Xu, L. Zhang, L. Liu, G. F. Liu and D. Z. Jia, Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of (1-phenyl-3-methyl-4-propenylidene-5--pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand, Polyhedron27 (2008) 12–24; https://doi.org/10.1016/j.poly.2007.08.04510.1016/j.poly.2007.08.045
17. J. Zhao, L. Zhang, J. Li, T. Wu, M. Wang, G. Xu, F. Zhang, L. Liu, J. Yang and S. Sun, A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway, Chem. Biol. Interact. 231 (2015) 1–9; https://doi.org/10.1016/j.cbi.2015.02.00410.1016/j.cbi.2015.02.00425684395
19. C. Chang, T. Wu, M. Wang, G. Xu and S. Sun, Antitumor effect of cadmium(II) complex of pyrazolone derivatives on melanoma B16 cells in vitro and in vivo, Chin. J. Pharmacol. Toxicol. 31 (2017) 405–413 (In Chinese).
20. G. Resta, G. Anania, F. Messina, D. D. Tullio, G. Ferrocci, F. Zanzi, D. Pellegrini, R. Stano, G. Cavallesco, G. Azzena and S. Occhionorelli, Jejuno-jejunal invagination due to intestinal melanoma, World. J. Gastroenterol. 13 (2007) 310; https://doi.org/10.3748/wjg.v13.i2.31010.3748/wjg.v13.i2.310406596417226915
21. A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M. L. Kuppusamy, S. Naidu, T. Ka´lai, K. Hideg and P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function complex, J. Pharmacol. Exp. Ther. 339 (2011) 350–357; https://doi.org/10.1124/jpet.111.18368110.1124/jpet.111.183681319999421799049
22. H. Yang, D. Chen, Q. C. Cui, X. Yuan and Q. P. Dou, Celastrol, a triterpene extracted from the chinese “thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer. Res. 66 (2006) 4758; https://doi.org/10.1158/0008-5472.can-05-452910.1158/0008-5472.CAN-05-452916651429
23. W. Jiang, J. Cao, B. Pan and Y. Yu, Clinical significance of serum vascular endothelial growth factor and b-fibroblast growth factor before and after chemotherapy in patients with small cell lung cancer, Chin. J. Clin. Oncol. 40 (2013) 638–642; https://doi.org/10.3969/j.issn.1000-8179.2013.11.006
24. S. Imura, H. Miyake, K. Izumi, S. Tashiro and H. Uehara, Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma, J. Med. Invest. 51 (2004) 202; https://doi.org/10.2152/jmi.51.20210.2152/jmi.51.20215460907